Romania · Delayed Price · Currency is RON Med Life Earnings Call Transcripts
Fiscal Year 2025
-
Turnover grew 19.5% to RON 2.36 billion in the first nine months, with hospitals and clinics leading growth. EBITDA rose 20.4%, but net profit dropped 88% due to FX losses. Investments focused on new facilities, AI, and genetic testing, while debt and CapEx were closely managed.
-
Turnover grew 20% to RON 1.57 billion in H1 2025, with 16% organic growth and strong EBITDA margin. Major acquisitions, tech investments, and new hospital units drove expansion, while FX losses and fiscal changes weighed on net results.
Fiscal Year 2024
-
2024 saw 25% revenue growth and a 43% rise in EBITDA, driven by organic expansion and five acquisitions. Margin and net debt/EBITDA improved, with new hospitals and digital services launched. 2025 will focus on completing ongoing projects and prudent M&A.